Načítá se...
PPARγ and Its Agonists in Chronic Kidney Disease
Chronic kidney disease (CKD) has become a global healthcare issue. CKD can progress to irreversible end-stage renal diseases (ESRD) or renal failure. The major risk factors for CKD include obesity, diabetes, and cardiovascular diseases. Understanding the key process involved in the disease developme...
Uloženo v:
| Vydáno v: | Int J Nephrol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7060840/ https://ncbi.nlm.nih.gov/pubmed/32158560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2917474 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|